InDepth information sheet downloaded from - http://www.bioportfolio.
com on Sunday, March 28, 2010
Pericoronitis View the current Pericoronitis InDepth page on BioPortfolio.com ( PDF) (http://www.bioportfolio.com/indepth/Pericoronitis.html) - Regularly Updated. Pericoronitis is a common problem in young adults with partial tooth impactions. It occurs when the wisdom tooth has failed to erupt completely through the gum bed, allowing bacteria into an open space around the tooth, causing infection. What Are the Symptoms of Pericoronitis?1. Pain 2. Infection 3. Swelling in the gum tissue 4. A "bad taste" in the mouth 5. Swelling of the lymph nodes in the neck 6. Difficulty opening the mouth Treatment is usually provision of antibiotics to control the infection. In cases where pericoronitis has recurred, with two or more episodes in the last year, removal of the impacted tooth is indicated.Pericoronitis that causes symptoms should be treated as soon as possible. If it is not, the infection can spread to other areas of the mouth. The most severe cases are treated in a hospital and may require intravenous antibiotics and surgery.nl:Pericoronitis Pericytes ( From the Wikpedia article Pericoronitis.) Recent Publications on Pericoronitis:
Wisdom teeth: mankind's future third vice-teeth? The third molar teeth (wisdom teeth) represent the last eruption of the...17th March, 2010 School of Stomatology, Tongji University, Shanghai 200072, China.- Med Hypotheses. 2010 Jan;74(1):52-5. Epub 2009 Sep 17. (DOI Direct Link) Radiographic quantification of chronic dental infection and its relationship to the atherosclerotic process in the carotid arteries. BACKGROUND: Atherosclerosis may be initiated/accelerated by chronic dental...26th January, 2010 Associate Chief of Staff and Director, Graduate Medical Education, VA- Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Jan 21. (DOI Direct Link) Assessment of the associated symptoms, pathologies, positions and angulations of bilateral occurring mandibular third molars: is there any similarity? OBJECTIVE: The aim of this study was to evaluate and establish any...16th December, 2009 Department of Oral Diagnosis and Radiology, Gazi University School of- Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Sep;108(3):e26-32. (DOI Direct Link) Pericoronitis: treatment and a clinical dilemma. Pericoronitis is an infection associated with impacted lower third molars...17th November, 2009 Dublin Dental Hospital, Dublin.- J Ir Dent Assoc. 2009 Aug-Sep;55(4):190-2. Importance of radiographs. Although radiolucency has been shown as a risk of infection, the poorly...30th October, 2009 - Br Dent J. 2009 Aug 8;207(3):96. (DOI Direct Link) Effect of Mercurius solubilis on the bacteriological response in the alveolitis process in rats. OBJECTIVE: The purpose of this study was to assess the bacteriological...16th October, 2009 Federal University of Pernambuco, Microbiology Division, Laboratory of- Homeopathy. 2009 Jul;98(3):160-4. (DOI Direct Link) 1/4 Interagency working. To minimize the risk of intraoperative complications, a comprehensive...16th September, 2009 - Br Dent J. 2009 Jun 13;206(11):562; author reply 562-3. (DOI Direct Link) Acute inflammation in horizontal incompletely impacted third molar with radiolucency in the elderly. Although radiolucency has been shown as a risk of infection, the poorly...22nd August, 2009 Matsumoto Dental University, Oral and Maxillofacial surgery, shiojiri,- Clin Interv Aging. 2009;4:337-42. Epub 2009 Aug 3. Delayed paresthesia of inferior alveolar nerve after extraction of mandibular third molar: case report and possible etiology. OBJECTIVE: The purpose of this study was to assess the bacteriological...21st August, 2009 Department of Oral and Maxillofacial Surgery, University of the Pacific- J Oral Maxillofac Surg. 2009 Aug;67(8):1764-6. (DOI Direct Link) Angulation of mandibular third molars as a predictive factor for pericoronitis. AIM: The aims of this study were to investigate the association between...6th August, 2009 Department of Oral Medicine and Oral Surgery, Faculty of Dentistry,- J Contemp Dent Pract. 2009 May 1;10(3):51-8. [Interradicular course of the inferior alveolar nerve at the mandibular right third molar and monostotic fibrous dysplasia affecting the mandibular left third molar in the same patient. A case report] To minimize the risk of intraoperative complications, a comprehensive...21st July, 2009 Klinik fur Oralchirurgie und Stomatologie, Zahnmedizinische Kliniken der- Schweiz Monatsschr Zahnmed. 2009;119(5):489-502. Evidenced-based decision making: the third molar. The American Association of Oral and Maxillofacial Surgeons (AAOMS) has...6th June, 2009 University of Kentucky College of Dentistry, D-136, 800 Rose Street, Room,- Dent Clin North Am. 2009 Jan;53(1):77-96, ix. (DOI Direct Link) Case report of self-injurious behaviour (SIB) presenting as gingivitis artefacta major. The case report described here discusses gingivitis artefacta major, an...12th May, 2009 Restorative Dentistry, 4th floor Edinburgh Dental Institute, Edinburgh.- Br Dent J. 2009 Feb 14;206(3):129-31. (DOI Direct Link) Clinical applications of dental lasers. Dental lasers currently have 24 clinical indications for use that are...1st April, 2009 University of Maryland Dental School, Baltimore, USA.- Gen Dent. 2009 Jan-Feb;57(1):47-59. Comparison of periodontal inflammatory disease in young adults with and without pericoronitis involving mandibular third molars. PURPOSE: To compare the prevalence and severity of periodontal...14th January, 2009 School of Dentistry, University of North Carolina, Chapel Hill, NC- J Oral Maxillofac Surg. 2009 Jan;67(1):134-9. (DOI Direct Link) Pericoronitis Patents:
5002769- Compositions for the sustained-release of chlorhexidine 6194434- Cycloalkylaminomethylpyrrolidine derivatives 6309669- Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix 2/4 6384050- Tricyclic amine derivatives 6391889- Cis-substituted aminocyclopropane derivatives 6410056- Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix 6448266- Substituted cyclobutylamine derivatives 6462040- Cis-substituted aminocyclopropane derivative 6462070- Photosensitizer conjugates for pathogen targeting 6191129- Bicyclic amine derivative 6184388- Substituted aminocycloalkylpyrrolidine derivatives and cis-substituted aminocycloalkylpyrrolidine derivatives 6146655- Flexible intra-oral bandage and drug delivery system 5023082- Sustained-release pharmaceutical compositions 5463053- Optically active pyridobenzoxazine derivatives 5587386- Optically active pyridonecarboxylic acid derivatives 5654318- Bicyclic amine derivatives 5696132- Pyridonecarboxylic acid derivatives 5767127- Optically active pyridonecarboxylic acid derivatives 6031102- Optically active pyridonecarboxylic acid derivatives 6121285- Substituted aminocycloalkylpyrrolidine derivatives and cis-substituted aminocycloalkylpyrrolidine derivatives 6488912- Treatment of dentoalveolar infections with taurolidine and/or taurultam 6503539- Matrix protein compositions for wound healing 7231122- Photonic crystal waveguides and systems using such waveguides 7232667- Keratinocyte growth factor-2 polynucleotides 7268155- Photosensitizer conjugates for pathogen targeting 7294352- Matrix protein composition for treating inflammation 7310466- Photonic crystal waveguides and systems using such waveguides 7331954- Photonic crystal fibers and medical systems including photonic crystal fibers 7349589- Photonic crystal fibers and medical systems including photonic crystal fibers 7459155- Treating abdominal pain due to pancreatitis with seaprose 7186843- Aminomethylpyrrolidine derivatives having aromatic substituents 7167622- Photonic crystal fibers and medical systems including photonic crystal fibers 6949662- Cis-substituted aminocyclopropane derivative 6573260- Cycloalkyl-substituted aminomethylpyrrolidine derivatives 6586604- Tricyclic amine derivatives 6656952- Cis-substituted fluoromethylpyrrolidine derivative 6693077- Keratinocyte growth factor-2 6720009- Matrix protein compositions for treating infection 6762181- Aminomethylpyrrolidine derivatives having aromatic substituents 6844010- Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix 6902743- Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix 7563805- Tri-, tetra-substituted-3-aminopyrrolidine derivative *** Resources from the NCBI used in this document, NCBI's standard disclaimer applies. Nothing in this document should be used in place of personal medical advice from your own qualified medical practitioner. See BioPortfolio.com User Agreement 3/4 Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472 Peter Barfoot peter.barfoot@bioportfolio.com All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Stafford House, 10 Prince of Wales Road, Dorchester, Dorset, DT1 1PW, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2010 - BioPortfolio Limited.